Bishal Gyawali, Professor at Queen’s University, shared on X:
“At conferences and in journal articles, let’s demand for complete transparent reporting of adverse events. Without this, there can be no informed discussion of risks and benefits.”
Title: Improved Adverse Event Reporting: It’s About Time
Authors: Laure-Anne Teuwen, Nathan Cherny, Bishal Gyawali.
Read the full article.
Jud Kimmel, Patient Advocate, commented:
“Thank you for sharing this paper, Bishal. As a patient, I see two effects of inadequate AE reporting among fellow patients. One is to downplay and then feel misled when AEs are worse than expected. Conversely, some think they’ll have all the possible AEs and catastrophize. Improved reporting will help to reduce both tendencies.”
This also can be interesting:
FDA Final Guidances on Clinical Trial Safety Reporting: What Investigators and Sponsors Need to Know
